Simple jQuery Dropdowns

Browsing by Author Yesim Aydinok

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)
1-Jan-2020Changing patterns in the epidemiology of β-thalassemiaAntonis Kattamis; Gian Luca Forni; Yesim Aydinok; Vip Viprakasit; National and Kapodistrian University of Athens; E.O. Ospedali Galliera; Faculty of Medicine, Siriraj Hospital, Mahidol University; Ege University Medical School
1-Jan-2011Continued improvement in myocardial T2* over two years of deferasirox therapy in β-thalassemia major patients with cardiac iron overloadDudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen Saleh Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege University Medical School; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut
1-Jan-2014Current approach to iron chelation in childrenYesim Aydinok; Antonis Kattamis; Vip Viprakasit; Ege University Medical School; University of Athens Medical School; Mahidol University
1-Jun-2012Deferasirox for up to 3 years leads to continued improvement of myocardial T2* in patients with β-thalassemia majorDudley J. Pennell; John B. Porter; Maria Domenica Cappellini; Lee Lee Chan; Amal El-Beshlawy; Yesim Aydinok; Hishamshah Ibrahim; Chi Kong Li; Vip Viprakasit; Mohsen S. Elalfy; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher; Royal Brompton Hospital; UCL; Universita degli Studi di Milano; University of Malaya Medical Centre; Cairo University; Ege Universitesi; Kuala Lumpur Hospital; Prince of Wales Hospital Hong Kong; Mahidol University; Ain Shams University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; American University of Beirut
18-Jun-2015Effects of deferasirox-deferoxamine on myocardial and liver iron in patients with severe transfusional iron overloadYesim Aydinok; Antonis Kattamis; M. Domenica Cappellini; Amal El-Beshlawy; Raffaella Origa; Mohsen Elalfy; Yurdanur Kilinç; Silverio Perrotta; Zeynep Karakas; Vip Viprakasit; Dany Habr; Niculae Constantinovici; Junwu Shen; John B. Porter; Ege University Medical School; University of Athens; Universita degli Studi di Milano; Cairo University; Universita degli Studi di Cagliari; Ain Shams University; Cukurova Universitesi; Child and of General and Specialist Surgery; Istanbul Tip Fakultesi; Mahidol University; Novartis Pharmaceuticals; Novartis International AG; UCL Cancer Institute
11-Jan-2018Efficacy and safety of ruxolitinib in regularly transfused patients with thalassemia: Results from a phase 2a studyAli T. Taher; Zeynep Karakas; Elena Cassinerio; Noppadol Siritanaratkul; Antonis Kattamis; Aurelio Maggio; Stefano Rivella; Norbert Hollaender; Bruyere Mahuzier; Brian Gadbaw; Yesim Aydinok; American University of Beirut Medical Center; Università degli Studi di Milano; The Children's Hospital of Philadelphia; National and Kapodistrian University of Athens; Novartis Pharma S.A.S.; Istanbul Üniversitesi Tıp Fakültesi; Faculty of Medicine, Siriraj Hospital, Mahidol University; Novartis International AG; Ege University Medical School; Novartis Pharmaceuticals Corporation; UOSD MICI-A.O. Ospedali Riuniti “Villa Sofia-Cervello” Palermo
1-Jun-2018MRI for the diagnosis of cardiac and liver iron overload in patients with transfusion-dependent thalassemia: An algorithm to guide clinical use when availability is limitedVip Viprakasit; Amr Ajlan; Yesim Aydinok; Basim A.A. Al Ebadi; Hany Dewedar; Ahmed S. Ibrahim; Lamis Ragab; Omar Trad; Ahmed S. Wataify; Lily L.L. Wong; Ali T. Taher; University of Babylon; Tawam Hospital; American University of Beirut Medical Center; Kasr El-Aini School of Medicine; Ege Üniversitesi; Ain Shams University; Mahidol University; King Abdulaziz University; Basra Centre for Hereditary Blood Diseases; Dubai Health Authority; Queen Elizabeth Hospital
1-Mar-2016Optimising iron chelation therapy with deferasirox for non-transfusion-dependent thalassaemia patients: 1-year results from the THETIS studyAli T. Taher; M. Domenica Cappellini; Yesim Aydinok; John B. Porter; Zeynep Karakas; Vip Viprakasit; Noppadol Siritanaratkul; Antonis Kattamis; Candace Wang; Zewen Zhu; Victor Joaquin; Marie José Uwamahoro; Yong Rong Lai; American University of Beirut Medical Center; Università degli Studi di Milano; Ege University Medical School; UCL; Istanbul Tip Fakultesi; Mahidol University; University of Athens; Novartis Pharmaceuticals; Novartis International AG; Guangxi Medical University
5-Apr-2012A phase 2 study of the safety, tolerability, and pharmacodynamics of FBS0701, a novel oral iron chelator, in transfusional iron overloadEllis J. Neufeld; Renzo Galanello; Vip Viprakasit; Yesim Aydinok; Antonio Piga; Paul Harmatz; Gian Luca Forni; Farrukh T. Shah; Rachael F. Grace; John B. Porter; John C. Wood; Jennifer Peppe; Amber Jones; Hugh Young Rienhoff; Harvard University; Universita degli Studi di Cagliari; Mahidol University; Ege University Medical School; Scienze Cliniche e Biologiche; UCSF Benioff Children's Hospital Oakland; E.O. Ospedali Galliera; Whittington Hospital; UCL; Children's Hospital Los Angeles; FerroKin BioSciences, Inc.
26-Mar-2020A phase 3 trial of luspatercept in patients with transfusion-dependent β-thalassemiaM. Domenica Cappellini; Vip Viprakasit; Ali T. Taher; Pencho Georgiev; Kevin H.M. Kuo; Thomas Coates; Ersi Voskaridou; Hong Keng Liew; Idit Pazgal-Kobrowski; G. L. Forni; Silverio Perrotta; Abderrahim Khelif; Ashutosh Lal; Antonis Kattamis; Efthymia Vlachaki; Raffaella Origa; Yesim Aydinok; Mohamed Bejaoui; P. Joy Ho; Lee Ping Chew; Ping Chong Bee; Soo Min Lim; Meng Yao Lu; Adisak Tantiworawit; Penka Ganeva; Liana Gercheva; Farrukh Shah; Ellis J. Neufeld; Alexis Thompson; Abderrahmane Laadem; Jeevan K. Shetty; Jun Zou; Jennie Zhang; Dimana Miteva; Tatiana Zinger; Peter G. Linde; Matthew L. Sherman; Olivier Hermine; John Porter; Antonio Piga; l'Institut des Maladies Génétiques Imagine; Azienda Ospedaliera Brotzu - Microcitemico; Centre National de Greffe de Moelle Osseuse; University Hospital St. Marina; American University of Beirut Medical Center; Hopital Farhat Hached Sousse; UCSF Benioff Children‘s Hospital; Università degli Studi di Milano; National and Kapodistrian University of Athens; St.George University Hospital; Hôpital Necker Enfants Malades; Università degli Studi della Campania Luigi Vanvitelli; Laikon General Hospital; UCL; Rabin Medical Center Israel; St. Jude Children's Research Hospital; Celgene Corporation; E.O. Ospedali Galliera; Royal Prince Alfred Hospital; University of Toronto; Keck School of Medicine of USC; University of Malaya Medical Centre; Hospital Sultanah Aminah; Università degli Studi di Torino; Faculty of Medicine, Siriraj Hospital, Mahidol University; Ege University Medical School; National Health Service; National Taiwan University; Hippokration General Hospital; Chiang Mai University; Celgene; Hospital Umum; Ann and Robert H. Lurie Children's Hospital of Chicago; Specialized Hospital for Active Treatment in Oncology; Hospital Sultanah Bahiyah; Acceleron Pharma